Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RKT vs GSK✓SelectedUSD · GSKRKT vs GSK performance historyLatest closeAs of+4.25%11/20
Stock and ETF performance explorer

RKT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1.5%
GSK return
+40.7%
Excess return
-39.2%
Maximum drawdown
-58.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+4.2%-0.1%+4.4%+4.3%
7D+0.3%-5.3%+5.6%+1.9%
30D+23.8%-3.7%+27.4%+25.2%
3M-2.2%-7.3%+5.1%-0.1%
6M+0.9%-4.2%+5.1%+2.0%
YTD-29.0%+0.9%-29.8%-29.0%
1Y-15.0%+7.3%-22.2%-16.4%
3Y+61.6%+52.7%+8.9%+41.8%
All+1.5%+40.7%-39.2%-15.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling